Translations:Diabetes medication/4/en

Several groups of drugs, mostly given by mouth, are effective in type 2 diabetes, often in combination. The therapeutic combination in type 2 may include several insulin isoforms or oral antihyperglycemic agents. As of 2020, 23 unique antihyperglycemic drug combinations were approved by the FDA. The first triple combination of oral anti-diabetics was approved in 2019, consisting of metformin, saxagliptin, and dapagliflozin. Another triple combination approval for metformin, linagliptin, and empagliflozin followed in 2020.